Invest in Neurocarrus

New first-in-class sensory neuron specific pain drug treats pain without risk of addiction

Oversubscribed

raised from 97 investors

INVEST

min $100

INVESTMENT TERMS

Future Equity

$11.25M valuation cap

neurocarrus.com

Monterey, CA

Drug candidate N-001 provides relief from severe pain in animals caused by inflammation or surgery.

N-001 cannot enter the brain and therefore cannot cause addiction.

N-001 provides pain relief equal to prescription drugs without side effects on muscles or balance.

N-001 is a targeted drug with a unique manufacturing process to discourage competitors.

Neurocarrus top scientific publications:

Future projections are not guaranteed